1. Setting health-based residue limits for contaminants in pharmaceuticals and medical devices;Conine;Qual. Assur.,1992
2. Using human data to protect the public’s health;Dourson;Regul. Toxicol. Pharmacol.,2001
3. European Medicines Agency (EMA), 2011. Concept Paper on the development of toxicological guidance for use in risk identification in the manufacture of different medicinal products in shared, facilities. EMA/CHMP/SWP/598303/2011.
4. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens;Felter;Crit. Rev. Toxicol.,2011
5. Determining cleaning validation acceptance limits for pharmaceutical manufacturing operations;Fourman;Pharm. Technol.,1993